Retatrutide 50 mg Research Reference – Draft
$450.00
Internal draft imported for compliance review. Not approved for public publication or sale.
Internal draft for compliance review. This product was imported from the Vectra peptide venture workbook and is not approved for public publication or sale.
No medical, dosing, diagnostic, treatment, or human-use claims have been added.
Workbook source: SKU Unit Econ. Launch flag: 0. Source note: Off by default at BPW cost. Revisit after China-LA cost is verified.
| Attributes | Value |
|---|---|
| Molecule |
Retatrutide |
| mg per vial |
50 |
| BPW SKU |
BPW_NOLABEL_RETA_50MG_10PK_VIAL |
| Workbook launch flag |
0 |
